Clinical trial
Study to Evaluate Potential Predictors of Relapse in Participants With Major Depressive Disorder (MDD)
NCT02489305
Study timeline
Study start (actual)2014-12-15Date precision: day
Registry last updated2025-02-03
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Depressive Disorder, Majorunresolved
Interventions
Sponsors & collaborators
Janssen Research & Development, LLClead sponsor
Mapped research locations
HoustonTexas, United States1ChicagoIllinois, United States1PhiladelphiaPennsylvania, United States1DallasTexas, United States1BirminghamAlabama, United States1CincinnatiOhio, United States1San DiegoCalifornia, United States1TampaFlorida, United States1DurhamNorth Carolina, United States1JacksonvilleFlorida, United States1OrlandoFlorida, United States1Ann ArborMichigan, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02489305 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.